Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

3,710.00p
   
  • Change Today:
    -40.00p
  • 52 Week High: 5,060.00
  • 52 Week Low: 3,225.00
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 1,809
  • Market Cap: £193.65m

Latest ShareCast News

Director dealings: Bioventix CFO raises stake

By Iain Gilbert

Date: Thursday 31 Oct 2024

(Sharecast News) - Bioventix revealed on Thursday that chief financial officer Bruce Hiscock had acquired 333 ordinary shares in the London-listed antibodies development and supply company.

BioVentix reports year of growth, warns of geopolitical risks

By Josh White

Date: Monday 28 Oct 2024

(Sharecast News) - BioVentix, a UK-based developer of high-affinity monoclonal antibodies for clinical diagnostics, reported a 6% improvement in full-year revenue on Monday, to £13.6m, up from £12.82m in the prior year.

BioVentix revenue, earnings rise in first half

By Josh White

Date: Monday 25 Mar 2024

(Sharecast News) - Monoclonal antibody specialist BioVentix reported a 13% rise in first-half revenue on Monday, to £6.7m, compared to £5.9m in the prior year.

Sunday share tips: Octopus Renewables Infrastruc... 19-Nov-2023 ShareCast
BioVentix revenue, profits improve in full-year ... 24-Oct-2022 ShareCast
Bioventix hikes interim dividend after revenue f... 28-Mar-2022 ShareCast
Bioventix revenue rises in tougher first half 29-Mar-2021 ShareCast
Bioventix appoints Bruce Hiscox as chief financi... 01-Jul-2020 ShareCast
Bioventix full-year revenue and profits improve 21-Oct-2019 ShareCast
Vitamin D antibodies drive first-half growth at ... 29-Mar-2019 ShareCast
Bioventix posts healthy profits, ups dividend; w... 08-Oct-2018 ShareCast
Bioventix ups dividend on improved profits 26-Mar-2018 ShareCast
Bioventix profits shoot higher on vit-D tests, b... 16-Oct-2017 ShareCast
Bioventix share price spikes after trading update 04-Sep-2017 ShareCast
Bioventix earnings surge thanks to sterling 27-Mar-2017 ShareCast
 
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 3,710.00p
Change Today -40.00p
% Change -1.07 %
52 Week High 5,060.00
52 Week Low 3,225.00
Volume 1,809
Shares Issued 5.22m
Market Cap £193.65m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
67.57% below the market average67.57% below the market average67.57% below the market average67.57% below the market average67.57% below the market average
40.00% above the sector average40.00% above the sector average40.00% above the sector average40.00% above the sector average40.00% above the sector average
Price Trend
12.65% below the market average12.65% below the market average12.65% below the market average12.65% below the market average12.65% below the market average
46.94% above the sector average46.94% above the sector average46.94% above the sector average46.94% above the sector average46.94% above the sector average
Income
Market averageMarket averageMarket averageMarket averageMarket average
14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average
Growth
43.12% below the market average43.12% below the market average43.12% below the market average43.12% below the market average43.12% below the market average
17.65% below the sector average17.65% below the sector average17.65% below the sector average17.65% below the sector average17.65% below the sector average

Bioventix Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 07-Nov-24 11-Apr-24
Paid 21-Nov-24 26-Apr-24
Amount 87.00p 68.00p

Trades for 21-Nov-2024

Time Volume / Share Price
16:24 0 @ 3,700.00p
16:24 1 @ 3,700.00p
15:46 12 @ 3,794.00p
15:23 24 @ 3,746.00p
15:01 144 @ 3,794.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page